Verseon's Anirban Datta Explains Challenges for Current Antiviral Drugs and Vaccines
Company suggests focusing on host-centric
approach for a new class of antivirals as a lasting solution to combat
SARS-CoV-2 and other viruses
Verseon's Anirban Datta Explains Challenges for Current Antiviral Drugs and Vaccines